Alaunos Therapeutics Inc TCRT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:10 PM EDT
1.21quote price arrow down-0.01 (-1.23%)
Volume
8,816
52 week range
0.66 - 9.89
Loading...
  • Open1.19
  • Day High1.22
  • Day Low1.18
  • Prev Close1.22
  • 52 Week High9.89
  • 52 Week High Date05/18/23
  • 52 Week Low0.66
  • 52 Week Low Date12/12/23

Key Stats

  • Market Cap19.295M
  • Shares Out16.01M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.28
  • YTD % Change13.63

KEY STATS

  • Open1.19
  • Day High1.22
  • Day Low1.18
  • Prev Close1.22
  • 52 Week High9.89
  • 52 Week High Date05/18/23
  • 52 Week Low0.66
  • 52 Week Low Date12/12/23
  • Market Cap19.295M
  • Shares Out16.01M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.28
  • YTD % Change13.63

RATIOS/PROFITABILITY

  • EPS (TTM)-1.67
  • P/E (TTM)-0.72
  • Fwd P/E (NTM)-0.67
  • EBITDA (TTM)-18.942M
  • ROE (TTM)-156.09%
  • Revenue (TTM)6,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-446,233.31%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alaunos Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
Holger Weis CPA
Independent Chairman of the Board
Dale Hogue Jr.
Interim Chief Executive Officer, Director
Abhishek Srivastava Ph.D.
Vice President - Technical Operations
Ferdinand Groenewald
Vice President - Finance
Address
2617 Bissonnet St, Suite 225
Houston, TX
77005
United States

Top Peers

SYMBOLLASTCHG%CHG
UNCY
Unicycive Therapeutics Inc
1.03UNCHUNCH
IMRX
Immuneering Corp
1.54UNCHUNCH
XLO
Xilio Therapeutics Inc
1.15+0.07+6.48%
MTNB
Matinas BioPharma Holdings Inc
0.176+0.003+1.7341%
INAB
IN8BIO, Inc.
1.03+0.01+0.98%